Astrana Health (NASDAQ:
ASTH) reported quarterly earnings of $0.29 per share which missed the analyst consensus estimate of $0.30 by 3.33 percent. This is a 107.14 percent increase over earnings of $0.14 per share from the same period last year. The company reported quarterly sales of $965.100 million which beat the analyst consensus estimate of $949.206 million by 1.67 percent. This is a 55.56 percent increase over sales of $620.390 million the same period last year.